News

EU Code Week tenders open for 2027-2030

Published on
| 3 months ago
Programmes
  • Culture and society
  • Advanced Digital Skills

The European Commission has published a call for tenders for EU Code Week activities covering 2027 to 2030. The contract is designed to support coding education, learning resources, outreach, community building and IT system development across Europe. 

The new contract aims to strengthen the EU Code Week community, attract more young people, help teachers use coding across subjects, improve coding and computational thinking skills, expand learning resources and training, increase outreach and registered activities, and support greater participation by girls in coding and digital skills development.

The successful contractor would be expected to run communication and engagement campaigns, manage and grow the community, develop learning resources, organise training and events, operate and develop the Code Week IT system, and monitor impact.

The opportunity is relevant for organisations with experience in digital education and skills, communication and outreach, and IT systems development and operation.

More information is available on the Commission website and through the EU Funding & Tenders Portal linked from that page.

Deadline for applications is 15 September 2026. 

Background:

EU Code Week is a European Commission-supported grassroots initiative that encourages people of all ages to explore coding and computational thinking, with the aim of making digital skills learning more accessible and engaging.

Related news

myOverview

Sign up for personalised information

Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.

  • News in your domains
  • Event announcements
  • A personal dashboard
Sign up now

Only for stakeholders located in Flanders

Latest news

2055 articles available Browse all news
  • Health

One Health AMR Partnership: Call 2027 opening soon

The European Partnership on One Health Antimicrobial Resistance (OH AMR) is about to launch the joint transnational call 2027 (JTC2027) “Understand, Model and Stop AMR Transmission”. The call opens on 18 November 2026. The call will follow a two-step evaluation process.Novel and improved measures are urgently required...

Read more
  • Enhancing EU R&I

ERA in Practice: A guide for the research and innovation community

The European Commission Directorate-General for Research & Innovation has published ERA in Practice: A Guide for the R&I Community, developed with the support of INSPIRING ERA. The publication connects the four European Research Area policy priorities for joint action of the Pact for Research and Innovation (2021), with practical tools...

Read more
  • Culture and society

SSH Opportunities document for the 2027 Horizon Europe calls updated

Net4Society, the NCP network for Cluster 2, has published an updated edition of the document "Opportunities for Researchers from the Social Sciences and Humanities (SSH) in Horizon Europe". This document is designed to help potential applicants to find SSH-related call topics across the different parts of Horizon Europe in Work Programmes...

Read more
  • Agro-Food, Environment

Topic update - HORIZON-CL6-2027-02-FARM2FORK-05

On 5 November 2026, the European Commission published a correction for Horizon Europe topic HORIZON-CL6-2027-02-FARM2FORK-05. Under the section ‘Topic description - Scope’, the sentence on collaboration with projects funded under other topics in the work programme has been updated. The original text referred to...

Read more

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.